Group 1 - The core viewpoint of the articles highlights the initiation of a profit recovery cycle in the domestic market driven by low inventory levels and a rebound in the second-hand housing market [1][2] - The active pharmaceutical sector is experiencing a vibrant market, with CXO and innovative drug companies leveraging talent and technology barriers to mitigate overseas policy risks [2] - The ETF market in China is witnessing significant growth, with passive equity fund sizes expected to surpass active equity funds for the first time in 2024, indicating a new era of ETF innovation [2][3] Group 2 - The consumption sector is anticipated to enter a recovery window in the second half of the year, with a focus on traditional consumer leaders and emerging consumption trends [1] - Smart Beta ETFs are gaining traction, with the global Smart Beta ETF market projected to reach $2.24 trillion in 2024, reflecting a 21.4% year-on-year growth [3] - The fixed income market is expected to face challenges due to low interest rates, but short-duration investments in quality credit assets are seen as opportunities for excess returns [4][5]
变局下重构投资范式 从不确定中挖掘确定机会
Zhong Guo Zheng Quan Bao·2025-05-25 21:09